Indokem（504092）株式概要インドケム・リミテッドはその子会社とともに、インド、中東、東アジア、ヨーロッパ、南米で染料、サイズ剤、助剤の製造、輸出、販売を行っている。 詳細504092 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績2/6財務の健全性3/6配当金0/6リスク分析利益率(1.1%)は昨年より低い(1.8%) すべてのリスクチェックを見る504092 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹594.8522.7% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-62m3b2016201920222025202620282031Revenue ₹3.3bEarnings ₹36.2mAdvancedSet Fair ValueView all narrativesIndokem Limited 競合他社S H KelkarSymbol: NSEI:SHKMarket cap: ₹17.6bTitan BiotechSymbol: BSE:524717Market cap: ₹18.6bVidhi Specialty Food IngredientsSymbol: BSE:531717Market cap: ₹14.7bUltramarine & PigmentsSymbol: BSE:506685Market cap: ₹11.9b価格と性能株価の高値、安値、推移の概要Indokem過去の株価現在の株価₹594.8552週高値₹930.0052週安値₹178.00ベータ0.331ヶ月の変化8.85%3ヶ月変化7.05%1年変化226.12%3年間の変化435.90%5年間の変化1,649.56%IPOからの変化2,024.46%最新ニュースNew Risk • May 18New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.1% Last year net profit margin: 1.8% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company.お知らせ • Apr 29Indokem Limited to Report Q4, 2026 Results on May 04, 2026Indokem Limited announced that they will report Q4, 2026 results on May 04, 2026New Risk • Mar 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • Jan 31Third quarter 2026 earnings released: EPS: ₹0.15 (vs ₹0.26 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.15 (down from ₹0.26 in 3Q 2025). Revenue: ₹441.0m (up 1.6% from 3Q 2025). Net income: ₹4.10m (down 45% from 3Q 2025). Profit margin: 0.9% (down from 1.7% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has increased by 77% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 22Indokem Limited to Report Q3, 2026 Results on Jan 30, 2026Indokem Limited announced that they will report Q3, 2026 results on Jan 30, 2026New Risk • Dec 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.最新情報をもっと見るRecent updatesNew Risk • May 18New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.1% Last year net profit margin: 1.8% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company.お知らせ • Apr 29Indokem Limited to Report Q4, 2026 Results on May 04, 2026Indokem Limited announced that they will report Q4, 2026 results on May 04, 2026New Risk • Mar 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • Jan 31Third quarter 2026 earnings released: EPS: ₹0.15 (vs ₹0.26 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.15 (down from ₹0.26 in 3Q 2025). Revenue: ₹441.0m (up 1.6% from 3Q 2025). Net income: ₹4.10m (down 45% from 3Q 2025). Profit margin: 0.9% (down from 1.7% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has increased by 77% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 22Indokem Limited to Report Q3, 2026 Results on Jan 30, 2026Indokem Limited announced that they will report Q3, 2026 results on Jan 30, 2026New Risk • Dec 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • Nov 18Second quarter 2026 earnings releasedSecond quarter 2026 results: EPS: ₹0.15. Revenue: ₹403.0m (down 6.9% from 2Q 2025). Net income: ₹4.10m (up ₹4.10m from 2Q 2025). Profit margin: 1.0% (up from 0% in 2Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 102% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Nov 05Indokem Limited to Report Q2, 2026 Results on Nov 13, 2025Indokem Limited announced that they will report Q2, 2026 results on Nov 13, 2025Reported Earnings • Aug 09First quarter 2026 earnings released: EPS: ₹0.25 (vs ₹0.50 loss in 1Q 2025)First quarter 2026 results: EPS: ₹0.25 (up from ₹0.50 loss in 1Q 2025). Revenue: ₹417.4m (up 13% from 1Q 2025). Net income: ₹7.00m (up ₹20.8m from 1Q 2025). Profit margin: 1.7% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 78% per year, which means it is well ahead of earnings.お知らせ • Aug 08Indokem Limited, Annual General Meeting, Sep 25, 2025Indokem Limited, Annual General Meeting, Sep 25, 2025, at 14:00 Indian Standard Time.お知らせ • Aug 02Indokem Limited to Report Q1, 2026 Results on Aug 08, 2025Indokem Limited announced that they will report Q1, 2026 results on Aug 08, 2025New Risk • Jul 24New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.2% average weekly change). Minor Risk Market cap is less than US$100m (₹8.46b market cap, or US$98.1m).New Risk • Jun 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₹6.85b market cap, or US$80.1m).お知らせ • May 01Indokem Limited to Report Q4, 2025 Results on May 09, 2025Indokem Limited announced that they will report Q4, 2025 results on May 09, 2025Reported Earnings • Feb 08Third quarter 2025 earnings released: EPS: ₹0.26 (vs ₹0.05 loss in 3Q 2024)Third quarter 2025 results: EPS: ₹0.26 (up from ₹0.05 loss in 3Q 2024). Revenue: ₹440.5m (up 9.4% from 3Q 2024). Net income: ₹7.40m (up ₹8.70m from 3Q 2024). Profit margin: 1.7% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 137 percentage points per year, which is a significant difference in performance.お知らせ • Jan 30Indokem Limited to Report Q3, 2025 Results on Feb 07, 2025Indokem Limited announced that they will report Q3, 2025 results at 12:15 PM, Indian Standard Time on Feb 07, 2025New Risk • Dec 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 44% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₹2.79b market cap, or US$32.7m).Reported Earnings • Nov 18Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: ₹433.4m (up 7.4% from 2Q 2024). Net income: ₹0 (up ₹46.5m from 2Q 2024). Profit margin: 0% (up from net loss in 2Q 2024). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 141 percentage points per year, which is a significant difference in performance.お知らせ • Nov 06Indokem Limited to Report Q2, 2025 Results on Nov 14, 2024Indokem Limited announced that they will report Q2, 2025 results on Nov 14, 2024Reported Earnings • Aug 14First quarter 2025 earnings released: ₹0.50 loss per share (vs ₹0.27 loss in 1Q 2024)First quarter 2025 results: ₹0.50 loss per share (further deteriorated from ₹0.27 loss in 1Q 2024). Revenue: ₹369.9m (up 19% from 1Q 2024). Net loss: ₹13.8m (loss widened 112% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 156 percentage points per year, which is a significant difference in performance.お知らせ • Aug 13Indokem Limited, Annual General Meeting, Sep 26, 2024Indokem Limited, Annual General Meeting, Sep 26, 2024, at 14:00 Indian Standard Time.お知らせ • Aug 07Indokem Limited to Report Q1, 2025 Results on Aug 13, 2024Indokem Limited announced that they will report Q1, 2025 results on Aug 13, 2024New Risk • Jun 14New major risk - Revenue and earnings growthEarnings have declined by 18% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₹2.79b market cap, or US$33.4m).New Risk • May 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₹2.25b market cap, or US$27.0m).お知らせ • May 24Indokem Limited to Report Q4, 2024 Results on May 30, 2024Indokem Limited announced that they will report Q4, 2024 results on May 30, 2024Reported Earnings • Feb 14Third quarter 2024 earnings released: ₹0.05 loss per share (vs ₹0.25 profit in 3Q 2023)Third quarter 2024 results: ₹0.05 loss per share (down from ₹0.25 profit in 3Q 2023). Revenue: ₹403.1m (up 40% from 3Q 2023). Net loss: ₹1.30m (down 122% from profit in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 159 percentage points per year, which is a significant difference in performance.お知らせ • Feb 13Indokem Limited Announces Board ChangesIndokem Limited announced Mr. Kailash Pershad and Mr. Bhalchandra Sontakke will complete their second and final term as an independent Directors of the Company and consequently will cease to be independent Directors on the Board of the Company w.e.f. close of business hours on 31st March, 2024.お知らせ • Feb 06Indokem Limited to Report Q3, 2024 Results on Feb 13, 2024Indokem Limited announced that they will report Q3, 2024 results on Feb 13, 2024Reported Earnings • Nov 11Second quarter 2024 earnings released: ₹1.67 loss per share (vs ₹0.20 profit in 2Q 2023)Second quarter 2024 results: ₹1.67 loss per share (down from ₹0.20 profit in 2Q 2023). Revenue: ₹405.5m (up 39% from 2Q 2023). Net loss: ₹46.5m (down ₹51.4m from profit in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 182 percentage points per year, which is a significant difference in performance.New Risk • Oct 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₹3.02b market cap, or US$36.3m).お知らせ • Oct 01Indokem Limited Announces Appointment of Arupkumar Basu as a Managing DirectorIndokem Limited announced that Mr. Arupkumar Basu, Non-executive Director of the Company has been appointed as Managing Director of the Company at the meeting of the Board of Directors of the Company held on 25th July, 2023 and approved by the shareholders at the 57th Annual General Meeting of the Company held on 31st August, 2023 with effect from the date of the scheme of amalgamation between the Company and Refnol Resins and Chemicals Limited becoming effective for the period of 3 consecutive years. The said scheme of amalgamation between the Company and Refnol Resins and Chemicals Limited has become effective from 29th September, 2023 after filing of necessary forms with Ministry of Corporate Affairs /Registrar of Companies, Mumbai on 29th September, 2023. Mr. Arup Kumar Basu (DIN: 00906760) is a B. Tech, Chemical Engineering from IIT, Bombay and has obtained a postgraduate management degree from IIM, Ahmedabad. and has an experience of over 40 years in this industry.Board Change • Aug 12High number of new directorsAdditional Non-Executive Director Arupkumar Basu was the last director to join the board, commencing their role in 2023.お知らせ • Jul 26Indokem Limited, Annual General Meeting, Aug 31, 2023Indokem Limited, Annual General Meeting, Aug 31, 2023, at 14:00 Indian Standard Time.Reported Earnings • Jul 26First quarter 2024 earnings released: ₹0.27 loss per share (vs ₹0.49 loss in 1Q 2023)First quarter 2024 results: ₹0.27 loss per share (improved from ₹0.49 loss in 1Q 2023). Revenue: ₹312.2m (up 20% from 1Q 2023). Net loss: ₹6.50m (loss narrowed 45% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has increased by 116% per year, which means it is well ahead of earnings.お知らせ • May 13Indokem Limited to Report Q4, 2023 Results on May 22, 2023Indokem Limited announced that they will report Q4, 2023 results at 3:30 PM, Indian Standard Time on May 22, 2023Reported Earnings • Feb 10Third quarter 2023 earnings released: EPS: ₹0.25 (vs ₹0.64 in 3Q 2022)Third quarter 2023 results: EPS: ₹0.25 (down from ₹0.64 in 3Q 2022). Revenue: ₹289.9m (down 15% from 3Q 2022). Net income: ₹6.00m (down 62% from 3Q 2022). Profit margin: 2.1% (down from 4.6% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 126% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 03Indokem Limited to Report Q3, 2023 Results on Feb 09, 2023Indokem Limited announced that they will report Q3, 2023 results on Feb 09, 2023Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹0.21 (vs ₹0.08 in 2Q 2022)Second quarter 2023 results: EPS: ₹0.21 (up from ₹0.08 in 2Q 2022). Revenue: ₹297.5m (up 22% from 2Q 2022). Net income: ₹4.90m (up 158% from 2Q 2022). Profit margin: 1.6% (up from 0.8% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has increased by 160% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Nov 05Indokem Limited to Report Q2, 2023 Results on Nov 11, 2022Indokem Limited announced that they will report Q2, 2023 results at 3:00 PM, Indian Standard Time on Nov 11, 2022Reported Earnings • Aug 11First quarter 2023 earnings released: ₹0.49 loss per share (vs ₹0.20 profit in 1Q 2022)First quarter 2023 results: ₹0.49 loss per share (down from ₹0.20 profit in 1Q 2022). Revenue: ₹268.8m (up 11% from 1Q 2022). Net loss: ₹11.8m (down 341% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has increased by 118% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 10Indokem Limited, Annual General Meeting, Sep 29, 2022Indokem Limited, Annual General Meeting, Sep 29, 2022, at 15:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹69.60, the stock trades at a trailing P/E ratio of 59.8x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 658% over the past three years.Reported Earnings • May 30Full year 2022 earnings released: EPS: ₹1.16 (vs ₹1.22 in FY 2021)Full year 2022 results: EPS: ₹1.16 (down from ₹1.22 in FY 2021). Revenue: ₹1.14b (up 44% from FY 2021). Net income: ₹28.3m (down 4.4% from FY 2021). Profit margin: 2.5% (down from 3.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 75% per year, which means it is significantly lagging earnings growth.お知らせ • May 19Indokem Limited to Report Q4, 2022 Results on May 26, 2022Indokem Limited announced that they will report Q4, 2022 results on May 26, 2022Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹58.50, the stock trades at a trailing P/E ratio of 45.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 408% over the past three years.Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 47% share price gain to ₹58.05, the stock trades at a trailing P/E ratio of 48.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 317% over the past three years.Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹40.85, the stock trades at a trailing P/E ratio of 34x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 158% over the past three years.Reported Earnings • Nov 03Second quarter 2022 earnings released: EPS ₹0.08 (vs ₹0.27 in 2Q 2021)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹244.3m (up 23% from 2Q 2021). Net income: ₹1.90m (down 71% from 2Q 2021). Profit margin: 0.8% (down from 3.3% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 16Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹39.80, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 72% over the past three years.Reported Earnings • Aug 18First quarter 2022 earnings released: EPS ₹0.20 (vs ₹0.02 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹245.1m (up 159% from 1Q 2021). Net income: ₹4.90m (up ₹4.30m from 1Q 2021). Profit margin: 2.0% (up from 0.6% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 30Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₹39.40, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 142% over the past three years.Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹46.90, the stock trades at a trailing P/E ratio of 38.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 235% over the past three years.Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹37.85, the stock trades at a trailing P/E ratio of 31x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 137% over the past three years.Reported Earnings • May 29Full year 2021 earnings released: EPS ₹1.22 (vs ₹0.21 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹794.7m (down 11% from FY 2020). Net income: ₹29.6m (up 480% from FY 2020). Profit margin: 3.7% (up from 0.6% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 96% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹36.85, the stock trades at a trailing P/E ratio of 30.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 92% over the past three years.Valuation Update With 7 Day Price Move • Apr 12Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹28.60, the stock trades at a trailing P/E ratio of 23.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 35% over the past three years.Reported Earnings • Feb 17Third quarter 2021 earnings released: EPS ₹0.56 (vs ₹0.23 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹222.3m (down 2.9% from 3Q 2020). Net income: ₹13.6m (up 139% from 3Q 2020). Profit margin: 6.1% (up from 2.5% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.お知らせ • Feb 03Indokem Limited to Report Q3, 2021 Results on Feb 12, 2021Indokem Limited announced that they will report Q3, 2021 results on Feb 12, 2021Valuation Update With 7 Day Price Move • Jan 15Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹23.45, the stock is trading at a trailing P/E ratio of 26.7x, down from the previous P/E ratio of 31.8x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 26%.Valuation Update With 7 Day Price Move • Jan 01Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹22.30, the stock is trading at a trailing P/E ratio of 25.4x, up from the previous P/E ratio of 21x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 37%.Is New 90 Day High Low • Dec 29New 90-day high: ₹19.63The company is up 70% from its price of ₹11.56 on 30 September 2020. The Indian market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period.Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improved over the past weekAfter last week's 23% share price gain to ₹19.09, the stock is trading at a trailing P/E ratio of 21.7x, up from the previous P/E ratio of 17.7x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 39%.Valuation Update With 7 Day Price Move • Dec 08Market bids up stock over the past weekAfter last week's 19% share price gain to ₹15.12, the stock is trading at a trailing P/E ratio of 17.2x, up from the previous P/E ratio of 14.5x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 47%.Is New 90 Day High Low • Dec 07New 90-day high: ₹13.80The company is up 17% from its price of ₹11.84 on 07 September 2020. The Indian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.Reported Earnings • Nov 12Second quarter 2021 earnings released: EPS ₹0.27The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: ₹199.5m (down 18% from 2Q 2020). Net income: ₹6.60m (up 408% from 2Q 2020). Profit margin: 3.3% (up from 0.5% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Oct 16Market bids up stock over the past weekAfter last week's 15% share price gain to ₹12.55, the stock is trading at a trailing P/E ratio of 20.1x, up from the previous P/E ratio of 17.4x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 64%.お知らせ • Aug 20Indokem Limited to Report Q1, 2021 Results on Aug 25, 2020Indokem Limited announced that they will report Q1, 2021 results on Aug 25, 2020お知らせ • Jul 10Indokem Limited to Report Q4, 2020 Results on Jul 16, 2020Indokem Limited announced that they will report Q4, 2020 results on Jul 16, 2020株主還元504092IN ChemicalsIN 市場7D1.6%0.3%0.5%1Y226.1%-2.9%-0.5%株主還元を見る業界別リターン: 504092過去 1 年間で-2.9 % の収益を上げたIndian Chemicals業界を上回りました。リターン対市場: 504092過去 1 年間で-0.5 % の収益を上げたIndian市場を上回りました。価格変動Is 504092's price volatile compared to industry and market?504092 volatility504092 Average Weekly Movement7.4%Chemicals Industry Average Movement7.3%Market Average Movement7.2%10% most volatile stocks in IN Market10.1%10% least volatile stocks in IN Market4.8%安定した株価: 504092 、 Indian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 504092の 週次ボラティリティ ( 8% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1946176Mahendra Khatauwww.indokem.co.inインドケム・リミテッドは子会社とともに、インド、中東、東アジア、ヨーロッパ、南米で染料、サイジングケミカル、助剤の製造、輸出、販売を行っている。繊維染料・化学品と電気コンデンサーの2つのセグメントで事業を展開している。同社は、ブレンド、柔軟剤、バインダー、潤滑剤、帯電防止液、コールドサイジングなどのサイジングケミカル、繊維助剤、桶染め、反応染料、直接染料、硫黄液染料、分散染料、酸性染料などの繊維染料、硫黄パウダー、繊維顔料を提供している。また、樹脂や化学品、電気コンデンサも提供している。同社は繊維、デニム、タオル、ニット、織物、シート、衣料品業界にサービスを提供している。インドケムは1946年に設立され、本社はインドのムンバイにある。もっと見るIndokem Limited 基礎のまとめIndokem の収益と売上を時価総額と比較するとどうか。504092 基礎統計学時価総額₹16.59b収益（TTM）₹18.70m売上高(TTM)₹1.69b887.1xPER（株価収益率9.8xP/Sレシオ504092 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計504092 損益計算書（TTM）収益₹1.69b売上原価₹1.13b売上総利益₹562.70mその他の費用₹544.00m収益₹18.70m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）0.67グロス・マージン33.22%純利益率1.10%有利子負債／自己資本比率41.6%504092 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 08:20終値2026/05/22 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Indokem Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • May 18New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.1% Last year net profit margin: 1.8% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company.
お知らせ • Apr 29Indokem Limited to Report Q4, 2026 Results on May 04, 2026Indokem Limited announced that they will report Q4, 2026 results on May 04, 2026
New Risk • Mar 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • Jan 31Third quarter 2026 earnings released: EPS: ₹0.15 (vs ₹0.26 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.15 (down from ₹0.26 in 3Q 2025). Revenue: ₹441.0m (up 1.6% from 3Q 2025). Net income: ₹4.10m (down 45% from 3Q 2025). Profit margin: 0.9% (down from 1.7% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has increased by 77% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 22Indokem Limited to Report Q3, 2026 Results on Jan 30, 2026Indokem Limited announced that they will report Q3, 2026 results on Jan 30, 2026
New Risk • Dec 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
New Risk • May 18New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.1% Last year net profit margin: 1.8% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company.
お知らせ • Apr 29Indokem Limited to Report Q4, 2026 Results on May 04, 2026Indokem Limited announced that they will report Q4, 2026 results on May 04, 2026
New Risk • Mar 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • Jan 31Third quarter 2026 earnings released: EPS: ₹0.15 (vs ₹0.26 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.15 (down from ₹0.26 in 3Q 2025). Revenue: ₹441.0m (up 1.6% from 3Q 2025). Net income: ₹4.10m (down 45% from 3Q 2025). Profit margin: 0.9% (down from 1.7% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has increased by 77% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 22Indokem Limited to Report Q3, 2026 Results on Jan 30, 2026Indokem Limited announced that they will report Q3, 2026 results on Jan 30, 2026
New Risk • Dec 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • Nov 18Second quarter 2026 earnings releasedSecond quarter 2026 results: EPS: ₹0.15. Revenue: ₹403.0m (down 6.9% from 2Q 2025). Net income: ₹4.10m (up ₹4.10m from 2Q 2025). Profit margin: 1.0% (up from 0% in 2Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 102% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Nov 05Indokem Limited to Report Q2, 2026 Results on Nov 13, 2025Indokem Limited announced that they will report Q2, 2026 results on Nov 13, 2025
Reported Earnings • Aug 09First quarter 2026 earnings released: EPS: ₹0.25 (vs ₹0.50 loss in 1Q 2025)First quarter 2026 results: EPS: ₹0.25 (up from ₹0.50 loss in 1Q 2025). Revenue: ₹417.4m (up 13% from 1Q 2025). Net income: ₹7.00m (up ₹20.8m from 1Q 2025). Profit margin: 1.7% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 78% per year, which means it is well ahead of earnings.
お知らせ • Aug 08Indokem Limited, Annual General Meeting, Sep 25, 2025Indokem Limited, Annual General Meeting, Sep 25, 2025, at 14:00 Indian Standard Time.
お知らせ • Aug 02Indokem Limited to Report Q1, 2026 Results on Aug 08, 2025Indokem Limited announced that they will report Q1, 2026 results on Aug 08, 2025
New Risk • Jul 24New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.2% average weekly change). Minor Risk Market cap is less than US$100m (₹8.46b market cap, or US$98.1m).
New Risk • Jun 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₹6.85b market cap, or US$80.1m).
お知らせ • May 01Indokem Limited to Report Q4, 2025 Results on May 09, 2025Indokem Limited announced that they will report Q4, 2025 results on May 09, 2025
Reported Earnings • Feb 08Third quarter 2025 earnings released: EPS: ₹0.26 (vs ₹0.05 loss in 3Q 2024)Third quarter 2025 results: EPS: ₹0.26 (up from ₹0.05 loss in 3Q 2024). Revenue: ₹440.5m (up 9.4% from 3Q 2024). Net income: ₹7.40m (up ₹8.70m from 3Q 2024). Profit margin: 1.7% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 137 percentage points per year, which is a significant difference in performance.
お知らせ • Jan 30Indokem Limited to Report Q3, 2025 Results on Feb 07, 2025Indokem Limited announced that they will report Q3, 2025 results at 12:15 PM, Indian Standard Time on Feb 07, 2025
New Risk • Dec 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 44% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₹2.79b market cap, or US$32.7m).
Reported Earnings • Nov 18Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: ₹433.4m (up 7.4% from 2Q 2024). Net income: ₹0 (up ₹46.5m from 2Q 2024). Profit margin: 0% (up from net loss in 2Q 2024). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 141 percentage points per year, which is a significant difference in performance.
お知らせ • Nov 06Indokem Limited to Report Q2, 2025 Results on Nov 14, 2024Indokem Limited announced that they will report Q2, 2025 results on Nov 14, 2024
Reported Earnings • Aug 14First quarter 2025 earnings released: ₹0.50 loss per share (vs ₹0.27 loss in 1Q 2024)First quarter 2025 results: ₹0.50 loss per share (further deteriorated from ₹0.27 loss in 1Q 2024). Revenue: ₹369.9m (up 19% from 1Q 2024). Net loss: ₹13.8m (loss widened 112% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 156 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 13Indokem Limited, Annual General Meeting, Sep 26, 2024Indokem Limited, Annual General Meeting, Sep 26, 2024, at 14:00 Indian Standard Time.
お知らせ • Aug 07Indokem Limited to Report Q1, 2025 Results on Aug 13, 2024Indokem Limited announced that they will report Q1, 2025 results on Aug 13, 2024
New Risk • Jun 14New major risk - Revenue and earnings growthEarnings have declined by 18% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₹2.79b market cap, or US$33.4m).
New Risk • May 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₹2.25b market cap, or US$27.0m).
お知らせ • May 24Indokem Limited to Report Q4, 2024 Results on May 30, 2024Indokem Limited announced that they will report Q4, 2024 results on May 30, 2024
Reported Earnings • Feb 14Third quarter 2024 earnings released: ₹0.05 loss per share (vs ₹0.25 profit in 3Q 2023)Third quarter 2024 results: ₹0.05 loss per share (down from ₹0.25 profit in 3Q 2023). Revenue: ₹403.1m (up 40% from 3Q 2023). Net loss: ₹1.30m (down 122% from profit in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 159 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 13Indokem Limited Announces Board ChangesIndokem Limited announced Mr. Kailash Pershad and Mr. Bhalchandra Sontakke will complete their second and final term as an independent Directors of the Company and consequently will cease to be independent Directors on the Board of the Company w.e.f. close of business hours on 31st March, 2024.
お知らせ • Feb 06Indokem Limited to Report Q3, 2024 Results on Feb 13, 2024Indokem Limited announced that they will report Q3, 2024 results on Feb 13, 2024
Reported Earnings • Nov 11Second quarter 2024 earnings released: ₹1.67 loss per share (vs ₹0.20 profit in 2Q 2023)Second quarter 2024 results: ₹1.67 loss per share (down from ₹0.20 profit in 2Q 2023). Revenue: ₹405.5m (up 39% from 2Q 2023). Net loss: ₹46.5m (down ₹51.4m from profit in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 182 percentage points per year, which is a significant difference in performance.
New Risk • Oct 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₹3.02b market cap, or US$36.3m).
お知らせ • Oct 01Indokem Limited Announces Appointment of Arupkumar Basu as a Managing DirectorIndokem Limited announced that Mr. Arupkumar Basu, Non-executive Director of the Company has been appointed as Managing Director of the Company at the meeting of the Board of Directors of the Company held on 25th July, 2023 and approved by the shareholders at the 57th Annual General Meeting of the Company held on 31st August, 2023 with effect from the date of the scheme of amalgamation between the Company and Refnol Resins and Chemicals Limited becoming effective for the period of 3 consecutive years. The said scheme of amalgamation between the Company and Refnol Resins and Chemicals Limited has become effective from 29th September, 2023 after filing of necessary forms with Ministry of Corporate Affairs /Registrar of Companies, Mumbai on 29th September, 2023. Mr. Arup Kumar Basu (DIN: 00906760) is a B. Tech, Chemical Engineering from IIT, Bombay and has obtained a postgraduate management degree from IIM, Ahmedabad. and has an experience of over 40 years in this industry.
Board Change • Aug 12High number of new directorsAdditional Non-Executive Director Arupkumar Basu was the last director to join the board, commencing their role in 2023.
お知らせ • Jul 26Indokem Limited, Annual General Meeting, Aug 31, 2023Indokem Limited, Annual General Meeting, Aug 31, 2023, at 14:00 Indian Standard Time.
Reported Earnings • Jul 26First quarter 2024 earnings released: ₹0.27 loss per share (vs ₹0.49 loss in 1Q 2023)First quarter 2024 results: ₹0.27 loss per share (improved from ₹0.49 loss in 1Q 2023). Revenue: ₹312.2m (up 20% from 1Q 2023). Net loss: ₹6.50m (loss narrowed 45% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has increased by 116% per year, which means it is well ahead of earnings.
お知らせ • May 13Indokem Limited to Report Q4, 2023 Results on May 22, 2023Indokem Limited announced that they will report Q4, 2023 results at 3:30 PM, Indian Standard Time on May 22, 2023
Reported Earnings • Feb 10Third quarter 2023 earnings released: EPS: ₹0.25 (vs ₹0.64 in 3Q 2022)Third quarter 2023 results: EPS: ₹0.25 (down from ₹0.64 in 3Q 2022). Revenue: ₹289.9m (down 15% from 3Q 2022). Net income: ₹6.00m (down 62% from 3Q 2022). Profit margin: 2.1% (down from 4.6% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 126% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 03Indokem Limited to Report Q3, 2023 Results on Feb 09, 2023Indokem Limited announced that they will report Q3, 2023 results on Feb 09, 2023
Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹0.21 (vs ₹0.08 in 2Q 2022)Second quarter 2023 results: EPS: ₹0.21 (up from ₹0.08 in 2Q 2022). Revenue: ₹297.5m (up 22% from 2Q 2022). Net income: ₹4.90m (up 158% from 2Q 2022). Profit margin: 1.6% (up from 0.8% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has increased by 160% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Nov 05Indokem Limited to Report Q2, 2023 Results on Nov 11, 2022Indokem Limited announced that they will report Q2, 2023 results at 3:00 PM, Indian Standard Time on Nov 11, 2022
Reported Earnings • Aug 11First quarter 2023 earnings released: ₹0.49 loss per share (vs ₹0.20 profit in 1Q 2022)First quarter 2023 results: ₹0.49 loss per share (down from ₹0.20 profit in 1Q 2022). Revenue: ₹268.8m (up 11% from 1Q 2022). Net loss: ₹11.8m (down 341% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has increased by 118% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 10Indokem Limited, Annual General Meeting, Sep 29, 2022Indokem Limited, Annual General Meeting, Sep 29, 2022, at 15:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹69.60, the stock trades at a trailing P/E ratio of 59.8x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 658% over the past three years.
Reported Earnings • May 30Full year 2022 earnings released: EPS: ₹1.16 (vs ₹1.22 in FY 2021)Full year 2022 results: EPS: ₹1.16 (down from ₹1.22 in FY 2021). Revenue: ₹1.14b (up 44% from FY 2021). Net income: ₹28.3m (down 4.4% from FY 2021). Profit margin: 2.5% (down from 3.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 75% per year, which means it is significantly lagging earnings growth.
お知らせ • May 19Indokem Limited to Report Q4, 2022 Results on May 26, 2022Indokem Limited announced that they will report Q4, 2022 results on May 26, 2022
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹58.50, the stock trades at a trailing P/E ratio of 45.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 408% over the past three years.
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 47% share price gain to ₹58.05, the stock trades at a trailing P/E ratio of 48.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 317% over the past three years.
Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹40.85, the stock trades at a trailing P/E ratio of 34x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 158% over the past three years.
Reported Earnings • Nov 03Second quarter 2022 earnings released: EPS ₹0.08 (vs ₹0.27 in 2Q 2021)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹244.3m (up 23% from 2Q 2021). Net income: ₹1.90m (down 71% from 2Q 2021). Profit margin: 0.8% (down from 3.3% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 16Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹39.80, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 72% over the past three years.
Reported Earnings • Aug 18First quarter 2022 earnings released: EPS ₹0.20 (vs ₹0.02 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹245.1m (up 159% from 1Q 2021). Net income: ₹4.90m (up ₹4.30m from 1Q 2021). Profit margin: 2.0% (up from 0.6% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 30Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₹39.40, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 142% over the past three years.
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹46.90, the stock trades at a trailing P/E ratio of 38.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 235% over the past three years.
Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹37.85, the stock trades at a trailing P/E ratio of 31x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 137% over the past three years.
Reported Earnings • May 29Full year 2021 earnings released: EPS ₹1.22 (vs ₹0.21 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹794.7m (down 11% from FY 2020). Net income: ₹29.6m (up 480% from FY 2020). Profit margin: 3.7% (up from 0.6% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 96% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹36.85, the stock trades at a trailing P/E ratio of 30.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 92% over the past three years.
Valuation Update With 7 Day Price Move • Apr 12Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹28.60, the stock trades at a trailing P/E ratio of 23.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 35% over the past three years.
Reported Earnings • Feb 17Third quarter 2021 earnings released: EPS ₹0.56 (vs ₹0.23 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹222.3m (down 2.9% from 3Q 2020). Net income: ₹13.6m (up 139% from 3Q 2020). Profit margin: 6.1% (up from 2.5% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
お知らせ • Feb 03Indokem Limited to Report Q3, 2021 Results on Feb 12, 2021Indokem Limited announced that they will report Q3, 2021 results on Feb 12, 2021
Valuation Update With 7 Day Price Move • Jan 15Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹23.45, the stock is trading at a trailing P/E ratio of 26.7x, down from the previous P/E ratio of 31.8x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 26%.
Valuation Update With 7 Day Price Move • Jan 01Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹22.30, the stock is trading at a trailing P/E ratio of 25.4x, up from the previous P/E ratio of 21x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 37%.
Is New 90 Day High Low • Dec 29New 90-day high: ₹19.63The company is up 70% from its price of ₹11.56 on 30 September 2020. The Indian market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period.
Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improved over the past weekAfter last week's 23% share price gain to ₹19.09, the stock is trading at a trailing P/E ratio of 21.7x, up from the previous P/E ratio of 17.7x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 39%.
Valuation Update With 7 Day Price Move • Dec 08Market bids up stock over the past weekAfter last week's 19% share price gain to ₹15.12, the stock is trading at a trailing P/E ratio of 17.2x, up from the previous P/E ratio of 14.5x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 47%.
Is New 90 Day High Low • Dec 07New 90-day high: ₹13.80The company is up 17% from its price of ₹11.84 on 07 September 2020. The Indian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.
Reported Earnings • Nov 12Second quarter 2021 earnings released: EPS ₹0.27The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: ₹199.5m (down 18% from 2Q 2020). Net income: ₹6.60m (up 408% from 2Q 2020). Profit margin: 3.3% (up from 0.5% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Oct 16Market bids up stock over the past weekAfter last week's 15% share price gain to ₹12.55, the stock is trading at a trailing P/E ratio of 20.1x, up from the previous P/E ratio of 17.4x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 64%.
お知らせ • Aug 20Indokem Limited to Report Q1, 2021 Results on Aug 25, 2020Indokem Limited announced that they will report Q1, 2021 results on Aug 25, 2020
お知らせ • Jul 10Indokem Limited to Report Q4, 2020 Results on Jul 16, 2020Indokem Limited announced that they will report Q4, 2020 results on Jul 16, 2020
